MannKind (Clinical Program Rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

MannKind (Clinical Program Rights) General Information

Description

A right for the development of pharmaceutical products. The asset comprises of worldwide rights to the immuno-therapeutic cancer, allergy and infectious disease clinical programs of MannKind.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 25134 Rye Canyon Loop
  • Suite 300
  • Valencia, CA 91355
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Colby Pharmaceutical
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 25134 Rye Canyon Loop
  • Suite 300
  • Valencia, CA 91355
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MannKind (Clinical Program Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MannKind (Clinical Program Rights)‘s full profile, request access.

Request a free trial

MannKind (Clinical Program Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MannKind (Clinical Program Rights)‘s full profile, request access.

Request a free trial

MannKind (Clinical Program Rights) FAQs

  • Where is MannKind (Clinical Program Rights) headquartered?

    MannKind (Clinical Program Rights) is headquartered in Valencia, CA.

  • What industry is MannKind (Clinical Program Rights) in?

    MannKind (Clinical Program Rights)’s primary industry is Buildings and Property.

  • Is MannKind (Clinical Program Rights) a private or public company?

    MannKind (Clinical Program Rights) is a Private company.

  • What is the current valuation of MannKind (Clinical Program Rights)?

    The current valuation of MannKind (Clinical Program Rights) is .

  • What is MannKind (Clinical Program Rights)’s current revenue?

    The current revenue for MannKind (Clinical Program Rights) is .

  • Who are MannKind (Clinical Program Rights)’s investors?

    MannKind has invested in MannKind (Clinical Program Rights).

  • When was MannKind (Clinical Program Rights) acquired?

    MannKind (Clinical Program Rights) was acquired on 13-Nov-2012.

  • Who acquired MannKind (Clinical Program Rights)?

    MannKind (Clinical Program Rights) was acquired by Colby Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process